Additionally, IL-33 and its receptor, growth stimulation expressed gene 2 (ST2), can also promote the progression of NASH with fibrosis by regulating CCL2 expression, thereby affecting monocyte recruitment that correlates with collagen expression in mice fed a high-fat diet (HFD) (52, 53). This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.